.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Boehringer Ingelheim
Accenture
Queensland Health
Chubb
Deloitte
UBS
Moodys
Daiichi Sankyo

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205353

« Back to Dashboard
NDA 205353 describes FARYDAK, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the FARYDAK profile page.

The generic ingredient in FARYDAK is panobinostat lactate. One supplier is listed for this compound. Additional details are available on the panobinostat lactate profile page.

Summary for 205353

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:5

Pharmacology for NDA: 205353

Suppliers and Packaging for NDA: 205353

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FARYDAK
panobinostat lactate
CAPSULE;ORAL 205353 NDA Novartis Pharmaceuticals Corporation 0078-0650 0078-0650-06 6 CAPSULE in 1 BLISTER PACK (0078-0650-06)
FARYDAK
panobinostat lactate
CAPSULE;ORAL 205353 NDA Novartis Pharmaceuticals Corporation 0078-0651 0078-0651-06 6 CAPSULE in 1 BLISTER PACK (0078-0651-06)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 10MG BASE
Approval Date:Feb 23, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 23, 2020
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Feb 23, 2022
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY
Patent:► SubscribePatent Expiration:Aug 31, 2021Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Cerilliant
Mallinckrodt
US Department of Justice
Chinese Patent Office
Queensland Health
UBS
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot